TG Therapeutics (TGTX) Misses Q2 EPS by 8c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/23/2026
- Nasdaq reaches record high close, AI stocks rally
- Meta AI agent triggers heavy selloff in banks, insurers, and travel stocks
- Exclusive: SB Energy Nasdaq IPO moving forward as planned
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
H.C. Wainwright Resumes TG Therapeutics (TGTX) at Buy
August 12, 2015 7:24 AM EDTH.C. Wainwright resumed coverage on TG Therapeutics (NASDAQ: TGTX) with a Buy rating and a price target of $22.00.
For an analyst ratings summary and ratings history on TG Therapeutics click here. For more ratings news on TG Therapeutics click here.
Shares of TG Therapeutics closed at $16.11 yesterday.
... MoreTG Therapeutics (TGTX) Continuing to Drive on All Cylinders; Roth Affirms 'Focus Pick' Rating
August 10, 2015 11:27 AM EDTRoth Capital reaffirms TG Therapeutics, Inc. (Nasdaq: TGTX) with a Focus Pick rating and $33 price target following... More
